Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
114,696,905
-
Share change
-
-6,167,198
-
Total reported value
-
$384,294,005
-
Put/Call ratio
-
220%
-
Price per share
-
$3.35
-
Number of holders
-
133
-
Value change
-
-$20,342,797
-
Number of buys
-
58
-
Number of sells
-
58
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q2 2021
As of 30 Jun 2021,
VBI VACCINES INC CDA - COM NEW (VBIV) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,696,905 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Cambridge Investment Research Advisors, Inc., CITADEL ADVISORS LLC, GENERAL AMERICAN INVESTORS CO INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
133
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.